Strategic Overview
OliLux develops DMN-Tre, a decentralized molecular test for TB diagnosis.
Innovation Portfolio
DMN-Tre
Early-stage decentralized molecular assay using novel trehalose-based sample preparation for MTBC detection. Designed for simplified workflow in resource-limited labs.
Molecular
Sputum
Key Milestones
DMN-Tre decentralized molecular test
District-level capability
Sputum-based testing
Early-stage clinical development